glp-1 and crohn's Glucagon-like peptide-1 receptor: mechanisms advances in therapy GLP-1 Use in Crohn's Disease:

Eur J Clin Nutr

Be aware that disabling cookies will affect the functionality of this and many other websites that you visit

There may be a role for microdosing in a few scenarios: When side-effects are not manageable: when side-effects are intolerable for patients, even on the lowest introductory dose, there may be a role for individualised approaches

However, the fact that it is a common and even expected circumstance doesnt make it any less frustrating for the patient who stops losing weight before they have reached their goal

Once I even had a spinal fracture due to steroid treatments and a vitamin D deficiency, which caused bone depletion